Cronos Group (CRON) Competitors

Cronos Group (NASDAQ:CRON) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.

Does the media refer more to CRON or ACB?

In the previous week, Cronos Group and Cronos Group both had 2 articles in the media. Cronos Group's average media sentiment score of 0.57 beat Aurora Cannabis' score of 0.00 indicating that Cronos Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aurora Cannabis	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has preferable valuation & earnings, CRON or ACB?

Cronos Group has higher earnings, but lower revenue than Aurora Cannabis. Cronos Group is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$117.61M	6.82	$41.08M	$0.13	16.00
Aurora Cannabis	$246.72M	1.04	$1.63M	$0.11	41.45

Do insiders & institutionals have more ownership in CRON or ACB?

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 6.9% of Cronos Group shares are owned by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Which has more risk & volatility, CRON or ACB?

Cronos Group has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.75, meaning that its share price is 75% more volatile than the S&P 500.

Do analysts prefer CRON or ACB?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Aurora Cannabis	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.67

Is CRON or ACB more profitable?

Cronos Group has a net margin of 39.69% compared to Aurora Cannabis' net margin of 1.32%. Aurora Cannabis' return on equity of 0.13% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	39.69%	-0.07%	-0.07%
Aurora Cannabis	1.32%	0.13%	0.10%

Summary

Aurora Cannabis beats Cronos Group on 9 of the 15 factors compared between the two stocks.